We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Injunction Cuts Short Actavis’ Marketing of Generic Pulmicort
Injunction Cuts Short Actavis’ Marketing of Generic Pulmicort
A federal appeals court issued an injunction halting sales of Actavis’ generic version of AstraZeneca’s inhaled asthma drug Pulmicort Respules, just four days after the generics maker launched its version.